Anivive Lifesciences
PrivateLast Round
Debt
Jan 27, 2025
Total Funding Raised
$98.5M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Anivive Lifesciences is a biotechnology company that develops therapeutics for animals.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, Healthcare Analytics
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Anivive Lifesciences Comparables
Compare Anivive Lifesciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Animal Life Sciences | 79% | |
| Torigen Pharmaceuticals, Inc. | 79% | |
| Elanco | 79% |
Anivive Lifesciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Jan 27, 2025 | ||||
| Grant | Aug 2, 2024 | ||||
| Grant | Jul 8, 2021 | ||||
| Series C | Apr 11, 2021 |
Key People
Founding team and executive leadership
Anivive Lifesciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institute of Allergy and Infectious Diseases | Grant |
| Leonid Capital Partners | Debt |
| Cypress Coast Investments | Series C |
| Food and Drug Administration | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 28, 2026
Monthly visitors grew 79% MoM, reaching 7.2K.
- Jan 19, 2026
Monthly visitors increased 55% MoM.
Anivive Lifesciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Anivive Lifesciences's valuation, stock price, and market status.
Is Anivive Lifesciences a public or private company?
Anivive Lifesciences is a private company.
What is the current stock price of Anivive Lifesciences?
Anivive Lifesciences is a private company, so its shares have no public market price. Caplight tracks Anivive Lifesciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Anivive Lifesciences worth (valuation)?
Valuation information for Anivive Lifesciences is not publicly available.
Can I buy Anivive Lifesciences stock?
Anivive Lifesciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Anivive Lifesciences's last funding round?
Anivive Lifesciences's most recent funding round was Debt on January 27, 2025.
Who are the main investors in Anivive Lifesciences?
Key investors in Anivive Lifesciences include National Institute of Allergy and Infectious Diseases, Leonid Capital Partners, Food and Drug Administration.
Will Anivive Lifesciences IPO soon?
No public IPO plans have been announced for Anivive Lifesciences.
How can I track Anivive Lifesciences secondary market activity?
Caplight tracks bids, offers, and trades in Anivive Lifesciences's shares on secondary markets.